Neutrophil diversity and function in health and disease
F Zhang,
Yidan Xia,
Jiayang Su
и другие.
Signal Transduction and Targeted Therapy,
Год журнала:
2024,
Номер
9(1)
Опубликована: Дек. 5, 2024
Abstract
Neutrophils,
the
most
abundant
type
of
granulocyte,
are
widely
recognized
as
one
pivotal
contributors
to
acute
inflammatory
response.
Initially,
neutrophils
were
considered
mobile
infantry
innate
immune
system,
tasked
with
immediate
response
invading
pathogens.
However,
recent
studies
have
demonstrated
that
versatile
cells,
capable
regulating
various
biological
processes
and
impacting
both
human
health
disease.
Cytokines
other
active
mediators
regulate
functional
activity
by
activating
multiple
receptors
on
these
thereby
initiating
downstream
signal
transduction
pathways.
Dysfunctions
in
disruptions
neutrophil
homeostasis
been
implicated
pathogenesis
numerous
diseases,
including
cancer
disorders,
often
due
aberrant
intracellular
signaling.
This
review
provides
a
comprehensive
synthesis
functions,
integrating
advancements
this
field.
Moreover,
it
examines
roles
signaling
pathways
involved
regulation
activity.
The
pathophysiology
diseases
emerging
therapeutic
approaches
targeting
them
also
elaborated.
addresses
current
limitations
within
field
research,
highlighting
critical
gaps
knowledge
warrant
further
investigation.
In
summary,
seeks
establish
multidimensional
model
regulation,
providing
new
perspectives
for
potential
clinical
applications
research.
Язык: Английский
Therapeutic Targeting of the Janus Kinase/Signal Transducer and Activator of Transcription Pathway in Cutaneous T-Cell Lymphoma
Cancers,
Год журнала:
2025,
Номер
17(4), С. 568 - 568
Опубликована: Фев. 7, 2025
Background/Objectives:
Cutaneous
T-cell
lymphoma
(CTCL)
is
a
rare
group
of
non-Hodgkin
lymphomas
characterized
by
the
clonal
expansion
malignant
T
cells.
While
current
treatments
can
alleviate
symptoms
and
significant
progress
has
been
made
in
treating
leukemic
CTCL,
definitive
cure
remains
elusive.
Dysregulation
Janus
kinase/signal
transducer
activator
transcription
(JAK/STAT)
signaling
pathway
key
driver
CTCL
pathogenesis.
As
result,
therapeutic
strategies
targeting
JAK/STAT
have
gained
momentum,
with
increasing
use
JAK
inhibitors
other
agents
that
effectively
suppress
this
pathway.
These
immune-modulating
therapies
broad
effects
on
physiological
processes,
inflammation,
pathological
changes
associated
both
inflammatory
diseases
cancers.
Several
inhibitors,
originally
FDA-approved
for
conditions,
are
now
being
investigated
cancer
treatment.
Methods:
In
paper,
brief
review
literature
dysregulation
provided,
highlighting
clinical
preclinical
studies
involving
target
Results:
Specifically,
we
focus
six
currently
under
investigation-golidocitinib,
ruxolitinib,
cerdulatinib,
tofacitinib,
upadacitinib,
abrocitinib.
Additionally,
discuss
explore
mechanisms
underlying
inhibition
CTCL.
Furthermore,
reported
cases
which
relapsed
or
emerged
following
inhibitor
Conclusions:
Collectively,
these
findings
support
potential
utility
However,
further
research
needed
to
evaluate
safety
risks,
minimize
adverse
effects,
optimize
strategies.
Язык: Английский
Rewiring the T cell-suppressive cytokine landscape of the tumor microenvironment: a new frontier for precision anti-cancer therapy
Frontiers in Immunology,
Год журнала:
2024,
Номер
15
Опубликована: Авг. 30, 2024
T
lymphocytes
that
infiltrate
the
tumor
microenvironment
(TME)
often
fail
to
function
as
effective
anti-cancer
agents.
Within
TME,
cell-to-cell
inhibitory
interactions
play
significant
roles
in
dampening
their
anti-tumor
activities.
Recent
studies
have
revealed
soluble
factors
released
TME
by
immune
and
non-immune
cells,
well
cells
themselves,
contribute
exacerbation
of
cell
exhaustion.
Our
understanding
cytokine
landscape
interrelationships,
impact
on
cancer
development
is
still
at
its
early
stages.
In
this
review,
we
aim
shed
light
Interleukin
(IL)
-6,
IL-9,
IL-10,
a
small
group
JAK/STAT
signaling-dependent
cytokines
harboring
cell-suppressive
effects
summarize
mechanisms
action.
Additionally,
will
explore
how
advancements
scientific
research
can
help
us
overcoming
obstacles
posed
suppress
tumors,
with
ultimate
objective
stimulating
further
investigations
for
novel
therapeutic
strategies
counteract
tumor-promoting
Язык: Английский
Targeting the JAK-STAT pathway in colorectal cancer: mechanisms, clinical implications, and therapeutic potential
Frontiers in Cell and Developmental Biology,
Год журнала:
2024,
Номер
12
Опубликована: Ноя. 26, 2024
Colorectal
cancer
(CRC)
remains
one
of
the
most
prevalent
and
fatal
malignancies
worldwide,
consistently
ranking
among
top
three
in
terms
incidence
mortality.
Despite
notable
advancements
early
detection
therapeutic
interventions,
survival
outcomes
for
advanced-stage
CRC
are
still
dismal,
largely
due
to
issues
such
as
drug
resistance
metastasis.
Recent
research
has
increasingly
implicated
JAK-STAT
signaling
pathway
a
pivotal
contributor
pathogenesis.
This
evolutionarily
conserved
plays
key
role
transmitting
extracellular
signals
nucleus,
thereby
modulating
gene
expression
involved
numerous
fundamental
biological
processes.
In
CRC,
dysregulation
is
frequently
observed
strongly
associated
with
tumor
progression,
including
processes
cellular
proliferation,
apoptosis,
metastasis,
immune
evasion,
sustenance
stem
cells.
Given
its
integral
advancement,
gained
recognition
viable
target.
Extensive
evidence
from
preclinical
clinical
models
supports
efficacy
safety
targeting
components
pathway,
presenting
new
possibilities
patients
particularly
addressing
enhancing
treatment
outcomes.
review
offers
detailed
exploration
focusing
on
regulatory
mechanisms
CRC-related
malignancies.
Moreover,
it
examines
association
between
protein
expression,
features,
prognosis,
potential
management.
Язык: Английский
Analysis of the potential biological significance of glycosylation in triple-negative breast cancer on patient prognosis
American Journal of Translational Research,
Год журнала:
2024,
Номер
16(6), С. 2212 - 2232
Опубликована: Янв. 1, 2024
Breast
cancer
is
the
most
common
malignancy
in
women,
with
its
prognosis
varying
greatly
according
to
subtype.
Triple-negative
breast
(TNBC)
has
worst
among
all
subtypes.
Glycosylation
a
critical
factor
influencing
of
patients
TNBC.
Our
aim
develop
tumor
model
by
analyzing
genes
related
glycosylation
predict
patient
outcomes.
Язык: Английский